Terms: = Ovarian cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Diagnosis
1228 results:
1. Construction and analysis of competitive endogenous RNA networks and prognostic models associated with ovarian cancer based on the exoRBase database.
Chen Z; Wang C; Ding J; Yu T; Li N; Ye C
PLoS One; 2024; 19(4):e0291149. PubMed ID: 38603733
[TBL] [Abstract] [Full Text] [Related]
2. Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
Ruiz F; Tjendra Y; Millan N; Gomez-Fernandez C; Pinto A
Am J Surg Pathol; 2024 May; 48(5):546-550. PubMed ID: 38357982
[TBL] [Abstract] [Full Text] [Related]
3. ovarian cancer survival in sub-Saharan Africa by human development index and histological subtypes: A population-based registry study.
Gizaw M; Parkin DM; Stöter O; Bukirwa P; Seife E; Chesumbai G; Korir A; Liu B; Manraj SS; Nda G; Somdyala NIM; Kantelhardt EJ
Int J Cancer; 2024 Jun; 154(11):1911-1919. PubMed ID: 38339849
[TBL] [Abstract] [Full Text] [Related]
4. Perceptions and experiences of fertility preservation in female patients with cancer in Greece.
Taniskidou AM; Voultsos P; Tarlatzis V; Timotheadou E
BMC Womens Health; 2024 Feb; 24(1):108. PubMed ID: 38336757
[TBL] [Abstract] [Full Text] [Related]
5. Variants in the first methionine of RAD51C are homologous recombination proficient due to an alternative start site.
Rein HL; Bernstein KA
DNA Repair (Amst); 2024 Mar; 135():103644. PubMed ID: 38330859
[TBL] [Abstract] [Full Text] [Related]
6. [Long-Term Survival of an Adolescent and Young Adult Patient with Unresectable Advanced Gastric cancer in Whom Multidisciplinary Treatment Was Effective].
Namikawa T; Utsunomiya M; Yokota K; Kawanishi Y; Yamaguchi S; Munekage M; Maeda H; Kitagawa H; Nagata Y; Kobayashi M; Hanazaki K; Seo S
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1985-1987. PubMed ID: 38303273
[TBL] [Abstract] [Full Text] [Related]
7. Pre-post feasibility trial of a telephone-delivered exercise intervention for patients during chemotherapy for recurrent ovarian cancer: the ECHO-R trial protocol.
Hayes SC; Spence RR; Janda M; Eakin E; Shannon C; Goh J; Beesley VL; Vagenas D; Webb P; Coward J; Gordon LG; O'Neill H; Williams M; Rye S; Newton MJ; Baniahmadi S; Nascimento M; Nicklin J; Garret A; Obermair A
BMJ Open; 2024 Jan; 14(1):e077158. PubMed ID: 38238061
[TBL] [Abstract] [Full Text] [Related]
8. Mini review of photoacoustic clinical imaging: a noninvasive tool for disease diagnosis and treatment evaluation.
Liu H; Wang M; Ji F; Jiang Y; Yang M
J Biomed Opt; 2024 Jan; 29(Suppl 1):S11522. PubMed ID: 38230369
[TBL] [Abstract] [Full Text] [Related]
9. Adnexal Masses: diagnosis and Management.
Wheeler V; Umstead B; Chadwick C
Am Fam Physician; 2023 Dec; 108(6):580-587. PubMed ID: 38215419
[TBL] [Abstract] [Full Text] [Related]
10. Deep Learning-Assisted Intelligent Artificial Vision Platform Based on Dual-Luminescence Eu(III)-Functionalized HOF for the diagnosis of Breast and ovarian cancer.
Hu Z; Yan B
Anal Chem; 2023 Dec; 95(51):18889-18897. PubMed ID: 38091264
[TBL] [Abstract] [Full Text] [Related]
11. Gynaecological cancer incidence and mortality trends in a Brazilian State with medium human development index: A 22-year analysis.
da Silva BEB; de Lemos LMD; Moura AR; Ferrari YAC; Lima MS; Santos MO; Lima CA
Cancer Epidemiol; 2024 Feb; 88():102493. PubMed ID: 38056244
[TBL] [Abstract] [Full Text] [Related]
12. The senescent mesothelial matrix accentuates colonization by ovarian cancer cells.
Thapa BV; Banerjee M; Glimm T; Saini DK; Bhat R
Cell Mol Life Sci; 2023 Dec; 81(1):2. PubMed ID: 38043093
[TBL] [Abstract] [Full Text] [Related]
13. Revealing the inhibitory effect of VASH1 on ovarian cancer from multiple perspectives.
Li Y; Meng L; Lou G
Cancer Biol Ther; 2023 Dec; 24(1):2285817. PubMed ID: 38010374
[TBL] [Abstract] [Full Text] [Related]
14. Top-Down Proteomics of Human Saliva, Analyzed with Logistic Regression and Machine Learning Methods, Reveal Molecular Signatures of ovarian cancer.
Scebba F; Salvadori S; Cateni S; Mantellini P; Carozzi F; Bisanzi S; Sani C; Robotti M; Barravecchia I; Martella F; Colla V; Angeloni D
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958700
[TBL] [Abstract] [Full Text] [Related]
15. Potential Significance of Serum Autoantibodies to Endometrial Antigens, α-Enolase and Hormones in Non-Invasive diagnosis and Pathogenesis of Endometriosis.
Menzhinskaya IV; Pavlovich SV; Melkumyan AG; Chuprynin VD; Yarotskaya EL; Sukhikh GT
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958566
[TBL] [Abstract] [Full Text] [Related]
16. Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study.
Ruan X; Huang D; Zhan Y; Huang J; Huang J; Ng AT; Tsu JH; Na R
Elife; 2023 Nov; 12():. PubMed ID: 37917154
[TBL] [Abstract] [Full Text] [Related]
17. cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.
Vylegzhanina AV; Bespalov IA; Novototskaya-Vlasova KA; Hall BM; Gleiberman AS; Yu H; Leontieva OV; Leonova KI; Kurnasov OV; Osterman AL; Dy GK; Komissarov AA; Vasilieva E; Gehlhausen J; Iwasaki A; Ambrosone CB; Tsuji T; Matsuzaki J; Odunsi K; Andrianova EL; Gudkov AV
Cancer Res Commun; 2023 Nov; 3(11):2256-2267. PubMed ID: 37870410
[TBL] [Abstract] [Full Text] [Related]
18. Glioma Single-Cell Biomechanical Analysis by Cyclic Conical Constricted Microfluidics.
Geng X; Zhou ZA; Mi Y; Wang C; Wang M; Guo C; Qu C; Feng S; Kim I; Yu M; Ji H; Ren X
Anal Chem; 2023 Oct; 95(42):15585-15594. PubMed ID: 37843131
[TBL] [Abstract] [Full Text] [Related]
19. Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer.
Shan D; Cheng S; Ma Y; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1039-1049. PubMed ID: 37724407
[TBL] [Abstract] [Full Text] [Related]
20. The role of OIP5 in the carcinogenesis and progression of ovarian cancer.
Zhang X; Gu W; Lin A; Duan R; Lian L; Huang Y; Li T; Sun Q
J Ovarian Res; 2023 Sep; 16(1):185. PubMed ID: 37660035
[TBL] [Abstract] [Full Text] [Related]
[Next]
